SWOT Analysis for Astal Laboratories Ltd. - Weakness

Add SWOT widget to your site/app

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Value Stocks, Under Radar (DVM)

Consistent Highest Return Stocks over Five Years

Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)

Stocks with Consistent Share Price Growth (subscription)

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 4 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Stock with Low PE (PE < = 10)

Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Declining Net Cash Flow : Companies not able to generate net cash

Stocks Underperforming their Industry Price Change in the Quarter

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks